drugset / Trial / NCT01404923

Effectiveness of On-demand Meteospasmyl® Use in Irritable Bowel Syndrome (IBS)

NCT01404923

Phase 4 Completed 436 enrolled Laboratoires Mayoly Spindler
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to compare the effectiveness of 2 IBS treatment strategies: * Strategy A = MeteoSpasmyl®, on-demand therapy * Strategy B = standard of care chosen by the physician

Timeline

Start
2009-12
Primary completion
2011-10
Completion
2011-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Alverine Small molecule
Subject simeticone Unknown